45
Savannah Therapeutics, Inc raises $3.9M under Reg D
Company raise · Raising · RIVERDALE, MD · Form D filed 2026-09-11
First raise on EDGARBusiness combinationNon-accredited investors
Why now — by persona
Relevant to: Executive & technical recruiting, B2B software & services sales, Commercial banking / treasury, D&O and management-liability insurance, Outsourced accounting / CFO. Lead card pending.
People on the filing
| Matthew Dowling | Director |
| Thomas Wollan | Executive Officer |
Signed by Jason Krause, Attorney/Authorized Representative.
Filing contact
The issuer's phone number and address from the filing are shown to subscribers. See plans, or read it on EDGAR.